Perspectives on Revised European Guidelines on Management of Bleeding and Coagulopathy Following Major Trauma.

Slides:



Advertisements
Similar presentations
An Essential Tool for Optimizing Clinical Outcomes and Improving Patient Safety: The Administrative and Clinical Standards for Patient Blood Management.
Advertisements

Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Massive transfusion: New Protocol
OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
Transfusing tiny soldiers Ramsey C. Tate, MD. Applying combat-derived massive transfusion protocols to pediatric trauma patients.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Omar Alsuhaibani Transfusion Medicine Journal Club February 2, 2010.
PLASMA TRANSFUSIONS Dr Oliver Karam, MD, MSc
Fluids and blood products in trauma
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
Transfusion Management of Massive Haemorrhage in Adults Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer.
Topics in Coagulation Donald M. Voltz, M.D. Assistant Professor of Anesthesiology Case Western Reserve University / University Hospitals of Cleveland.
Chapter 38 Hematologic Disorders and Oncologic Emergencies Unit 8 Multisystem Alterations Seventh Edition Linda D. Urden Kathleen M. Stacy Mary E. Lough.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Multimodal Management of Opioid-Induced Constipation
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
“Running with the Bulls” Massive Transfusion in the ED
Warfarin Toxicity Treatment & Management
Addressing the Challenges in Primary and Secondary Stroke Prevention
In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD,
Updated Information to Control Bleeding
This program will include a discussion of agents not approved by the FDA for use in the US
COPD by the Guidelines.
Coagulation Cascade of the Newborn
Oral Anticoagulants and Reversal Agents
NOACs for Cancer-Associated Thrombosis:
New Concepts in Peripheral Artery Disease: Emerging Role of Antithrombotics.
Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents.
NOACs In Long-term VTE Treatment: A State Of The Art Review
The Clinical Enigma of Cardiogenic Shock
Thrombosis, Cancer, and NOACs
UNDERSTANDING RISK STRATIFICATION IN PAH:
New Strategies to Prevent CV Events After Hospital Discharge
Emergency Management of NOAC Bleeding
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
How I treat patients with massive hemorrhage
Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.
Oral Anticoagulants in AFa,b A Brief History.
Improving Surgical Patient Safety
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Treatment algorithm for the management of idiopathic epilepsy that I have developed. Treatment algorithm for the management of idiopathic epilepsy that.
Anticoagulation Therapy in Patients Post-TAVR
Updates in Pulmonary Arterial Hypertension
Reversal of Direct Oral Anticoagulants (DOAC)
AF and PCI in Practice.
VTE in Cancer.
Reversal Strategies for VKA: Truths and Misconceptions
Menno V. Huisman, MD, PhD, John Fanikos, RPh, MBA 
Treatment of Thromboembolic Disease The Need for Multiple Perspectives
Coagulation Disorders Importance in surgical practice
Factor Xa Inhibitors in PAD
Cancer-Associated Thrombosis
Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?
Oral Prostacyclin Pathway Agents in PAH
Drugs Affecting Blood.
Program Goals Background: Anticoagulation in Patients With VTE.
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes
Improving Adherence to Antiplatelet Therapy After an ACS Event
Perspective on the Multidisciplinary Management of PAH
Patient Stories in PAH: Sequential Therapy in a FC II Patient
Saving the Day.
Selecting Treatment Approaches in Hemophilia
Trauma Resuscitations, Past, Present and Future Practices
Evaluating the Science of Cardiogenic Shock
Blood Components Dosage And Their Administration
ESC Guideline on the Management of STEMI Recommendation for DAPT
Key Data on Improving Outcomes in HF Patients
Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest?
Presentation transcript:

Perspectives on Revised European Guidelines on Management of Bleeding and Coagulopathy Following Major Trauma

Faculty and Agenda

Key Highlights From the 2019 Guidelines on Management of Major Bleeding and Coagulopathy

Methodology of Guidelines' Development

Recommendation 15: Restrictive Volume Resuscitation Strategy

Recommendation 24: Initial Management of Massive Hemorrhage

Disseminating and Implementing the Guidelines

A Look Back at the 2016 Guidelines on Major Bleeding and Coagulopathy: What Was Working/What Was Not

The European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma: Fifth Edition - Key Changes

Recommendation 32: Antithrombotic Agent Reversal

Recommendation 34: Direct Oral Anticoagulants - FXa Inhibitors

Recommendation 32: Rationale for Antithrombotic Agent Reversal

Recommendation 10: Coagulation Monitoring

Coagulopathy Diagnostic: Viscoelastic Techniques

Recommendation 28: Fibrinogen Supplementation

Promulgation and Implementation of the European Guidelines on Major Bleeding and Coagulopathy

FAST CT Scanning

Treatment Algorithms for Critical Trauma Cases

Role of Guidelines in Trauma Care

S3 Guideline on Treatment of Patients With Severe and Multiple Injuries

European Guidelines: Fifth Edition

Treatment Algorithm Pre-Hospital: Stop the Bleeding

The CRASH-2 Trial: Results of Administration of TXA

Fibrinogen and Hemostasis in Massive Bleeding

The Main Components of the Coagulation Cascade: Key Role of Fibrinogen

Fixed-Ratio Transfusion Protocol vs Goal-Directed Protocol

Treatment Algorithm: Block Lysis, Then Stimulate Clotting

Time Course of Plasma Fibrinogen During the First 7 Days After Trauma Categorized According to the Dose of FC Administered

Abbreviations

Abbreviations (cont)

Abbreviations (cont)